Research Progress in Intestinal Microecology in Pancreatic Cancer Diagnosis and Treatment

Overview

Journal J Oncol

Specialty Oncology

Date 2022 Dec 13

PMID 36510609

Authors

Zetao Han

Haiyan Zhang

Lu Lu

Xin Li

Caoyu Zhang

Jiajie Zhu

Chaonan Li

Qingjing Wang

Keda Chen

Affiliations

Soon will be listed here.

Abstract

The intestinal microbiota has an increasingly recognized role in the development of cancer, in which microbial interactions play a more important than expected role. Pancreatic cancer is a highly fatal disease, in which its mortality is closely related to its morbidity. Early detection is the best chance of improving survival. Through an in-depth understanding of the pancreatic cancer microbiota, we could establish screening or early diagnosis methods for pancreatic cancer, implement bacterial treatment, adjust the therapeutic effect, and even reduce adverse reactions. These would lead to new developments and provide hope for patients with pancreatic cancer. Herein, we review the progress in intestinal microbiology research to diagnose and treat pancreatic cancer.

Citing Articles

Advances in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Premalignant Pancreatic Lesions.

Yamada R, Tsuboi J, Murashima Y, Tanaka T, Nose K, Nakagawa H Biomedicines. 2023; 11(6).

PMID: 37371782 PMC: 10296512. DOI: 10.3390/biomedicines11061687.

References

Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W . Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019; 178(4):795-806.e12. PMC: 7288240. DOI: 10.1016/j.cell.2019.07.008. View

Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J . An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-31. DOI: 10.1038/nature05414. View

Li L, Zhang Y, Liu X, Meng X, Zhao R, Ou L . Periodontitis Exacerbates and Promotes the Progression of Chronic Kidney Disease Through Oral Flora, Cytokines, and Oxidative Stress. Front Microbiol. 2021; 12:656372. PMC: 8238692. DOI: 10.3389/fmicb.2021.656372. View

Kountouras J, Zavos C, Chatzopoulos D . Autoimmune pancreatitis, Helicobacter pylori infection, and apoptosis: a proposed relationship. Pancreas. 2005; 30(2):192-3. DOI: 10.1097/01.mpa.0000151576.91790.f8. View

Coutzac C, Jouniaux J, Paci A, Schmidt J, Mallardo D, Seck A . Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat Commun. 2020; 11(1):2168. PMC: 7195489. DOI: 10.1038/s41467-020-16079-x. View

Meng C, Bai C, Brown T, Hood L, Tian Q . Human Gut Microbiota and Gastrointestinal Cancer. Genomics Proteomics Bioinformatics. 2018; 16(1):33-49. PMC: 6000254. DOI: 10.1016/j.gpb.2017.06.002. View

Chen S, Chieng W, Huang S, Hsu L, Jan M . The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine. Sci Rep. 2020; 10(1):20319. PMC: 7683550. DOI: 10.1038/s41598-020-77322-5. View

Lu H, Ren Z, Li A, Li J, Xu S, Zhang H . Tongue coating microbiome data distinguish patients with pancreatic head cancer from healthy controls. J Oral Microbiol. 2019; 11(1):1563409. PMC: 6352935. DOI: 10.1080/20002297.2018.1563409. View

Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D . The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013; 342(6161):971-6. PMC: 4048947. DOI: 10.1126/science.1240537. View

10.

Lu S, Hua J, Xu J, Wei M, Liang C, Meng Q . Microorganisms in chemotherapy for pancreatic cancer: An overview of current research and future directions. Int J Biol Sci. 2021; 17(10):2666-2682. PMC: 8315022. DOI: 10.7150/ijbs.59117. View

11.

Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M . Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009; 361(22):2135-42. DOI: 10.1056/NEJMoa0903068. View

12.

Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim J . The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019; 574(7777):264-267. PMC: 6858566. DOI: 10.1038/s41586-019-1608-2. View

13.

Pushalkar S, Hundeyin M, Daley D, Zambirinis C, Kurz E, Mishra A . The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov. 2018; 8(4):403-416. PMC: 6225783. DOI: 10.1158/2159-8290.CD-17-1134. View

14.

Del Castillo E, Meier R, Chung M, Koestler D, Chen T, Paster B . The Microbiomes of Pancreatic and Duodenum Tissue Overlap and Are Highly Subject Specific but Differ between Pancreatic Cancer and Noncancer Subjects. Cancer Epidemiol Biomarkers Prev. 2018; 28(2):370-383. PMC: 6363867. DOI: 10.1158/1055-9965.EPI-18-0542. View

15.

Luan C, Xie L, Yang X, Miao H, Lv N, Zhang R . Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas. Sci Rep. 2015; 5:7980. PMC: 4648387. DOI: 10.1038/srep07980. View

16.

Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A . Microbial short-chain fatty acids modulate CD8 T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021; 12(1):4077. PMC: 8249424. DOI: 10.1038/s41467-021-24331-1. View

17.

Tanoue T, Morita S, Plichta D, Skelly A, Suda W, Sugiura Y . A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 2019; 565(7741):600-605. DOI: 10.1038/s41586-019-0878-z. View

18.

Farrell J, Zhang L, Zhou H, Chia D, Elashoff D, Akin D . Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2011; 61(4):582-8. PMC: 3705763. DOI: 10.1136/gutjnl-2011-300784. View

19.

Orth M, Metzger P, Gerum S, Mayerle J, Schneider G, Belka C . Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiat Oncol. 2019; 14(1):141. PMC: 6688256. DOI: 10.1186/s13014-019-1345-6. View

20.

Routy B, Gopalakrishnan V, Daillere R, Zitvogel L, Wargo J, Kroemer G . The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol. 2018; 15(6):382-396. DOI: 10.1038/s41571-018-0006-2. View